High-dose intravenous vancomycin therapy and the risk of nephrotoxicity

Clinical Therapeutics

Volumn 36, Issue 7, 2014, Pages 1098-1101

  Rostas, Sara E ^a   Kubiak, David W ^a   Calderwood, Michael S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

acute kidney injury; dose response relationship; drug; vancomycin

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; DRUG BLOOD LEVEL; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; ACUTE KIDNEY INJURY; CHEMICALLY INDUCED; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL RECORD; MIDDLE AGED; MULTIVARIATE ANALYSIS;

ACUTE KIDNEY INJURY; ADMINISTRATION, INTRAVENOUS; ADULT; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN;

EID: 84904792402     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2014.05.011     Document Type: Article

References (12)

1. A. Wong-Beringer, J. Joo, E. Tse, and P. Beringer Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy Int J Antimicrob Agents 37 2011 95 101
2. S. Elvasi, H. Khalili, S. Dashti-Khavidaki, and A. Mohammadpour Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations: a literature review Eur J Clin Pharmacol 68 2012 1243 1255
3. S.J. van Hal, D.L. Paterson, and T.P. Lodise Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter Antimicrob Agents Chemother 57 2013 734 744
4. M. Rybak, B. Lomaestro, and J.C. Rotschafer et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists Am J Health Syst Pharm 66 2009 82 98
5. C. Liu, A. Bayer, and S.E. Cosgrove et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children Clin Infect Dis 52 2011 e18 e55
6. G.M. Chertow, and E. Burdick Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients J Am Soc Nephrol 16 2005 3365 3370
7. T.P. Lodise, B. Lomaestro, J. Graves, and G.L. Drusano Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity Antimicrob Agents Chemother 52 2008 1330 1336
8. M.A. Winter, K.N. Guhr, and G.M. Berg Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation Pharmacotherapy 32 2012 604 612
9. L.K. Hidayat, D.I. Hsu, and R. Quist et al. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity Arch Intern Med 166 2006 2138 2144
10. K.K. Prabaker, T.P. Tran, and T. Pratummas et al. Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans J Hosp Med 7 2012 91 97
11. K.A. Hazlewood, S.D. Brouse, W.D. Pitcher, and R.G. Hall Vancomycin-associated nephrotoxicity: grave concern or death by character assassination? Am J Med 123 2010 182.e1 182.e7
12. R.G. Hall, K.A. Hazlewood, and S.D. Brouse et al. Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistent Staphylococcus aureus bacteremia: a retrospective cohort study BMC Pharmacol Toxicol 14 2013 12